EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease

Anja Hess iD, Stefan D Gentile iD, Amel Ben Saad iD, Raza-Ur Rahman iD, Tim Habboub, Daniel S Pratt, Alan C Mullen iD

The EMBO Journal · 11.12.2023 · 42 (24)

DOI: 10.15252/embj.2023113898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The EMBO Journal, online erschienen am 14.11.2023. Verfasst von Anja Hess und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Studienstiftung des Deutschen Volkes (Studienstiftung), PSC Partners Seeking a Cure Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing cause of morbidity with limited treatment options. Thus, accurate in vitro systems to test new therapies are indispensable. While recently, human liver organoid models have emerged to assess steatotic liver disease, a systematic evaluation of their translational potential is still missing. Here, we evaluated human liver organoid models of MASLD, comparatively testing disease induction in three conditions: oleic acid, palmitic acid, and TGF‐β1. Through single‐cell analyses, we find that all three models induce inflammatory signatures, but only TGF‐β1 promotes collagen production, fibrosis, and hepatic stellate cell expansion. In striking contrast, oleic acid ameliorates fibrotic signatures and reduces the hepatic stellate cell population. Linking data from each model to gene expression signatures associated with MASLD disease progression further demonstrates that palmitic acid and TGF‐β1 more robustly model inflammation and fibrosis. Our findings highlight the importance of stratifying MASLD organoid models by signatures of clinical disease progression, provide a single‐cell reference to benchmark future organoid injury models, and allow us to study evolving steatohepatitis, fibrosis, and HSC susceptibility to injury in a dynamic, multi‐lineage human in vitro system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisFatty LiverHumansTransforming Growth Factor beta1Gene Expression ProfilingDisease Progression

Stichwörter der Autor:innen

MASLDNAFLDfibrosisliver organoidssingle-cell RNA-sequencing

Substanzen

Transforming Growth Factor beta1

Autor:innen und Institutionen

  • Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Autoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, MA, USA.
  • Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Stem Cell Institute, Cambridge, MA, USA.

ORCID-Profile: Anja Hess, Stefan D Gentile, Amel Ben Saad, Raza-Ur Rahman, Alan C Mullen

Förderung

  • NIDDK NIH HHS
  • Studienstiftung des Deutschen Volkes (Studienstiftung)
  • PSC Partners Seeking a Cure Canada
  • Massachusetts General Hospital (MGH)

Zitieren

APA

Hess, A., Gentile, S. D., Ben Saad, A., Rahman, R. U., Habboub, T., Pratt, D. S., & Mullen, A. C. (2023). Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease. The EMBO Journal, 42(24). https://doi.org/10.15252/embj.2023113898

Vancouver

Hess A, Gentile SD, Ben Saad A, Rahman RU, Habboub T, Pratt DS, et al. Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease. The EMBO Journal. 2023;42(24). doi:10.15252/embj.2023113898

BibTeX
@article{Hess2023,
  author = {Hess, Anja and Gentile, Stefan D and Ben Saad, Amel and Rahman, Raza-Ur and Habboub, Tim and Pratt, Daniel S and Mullen, Alan C},
  title = {Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease},
  journal = {The EMBO Journal},
  year = {2023},
  volume = {42},
  number = {24},
  doi = {10.15252/embj.2023113898}
}
Kostenlos starten →